p38-MAPK inhibitor MAPK13-IN-1, Purity ≥98%

Synonym: MAPK13-IN-1; 229002-10-2; 1-(3-tert-Butyl-1-Methyl-1H-Pyrazol-5-Yl)-3-[4-(Pyridin-4-Yloxy)phenyl]urea; CHEMBL472620; 1-(5-tert-Butyl-2-methylpyrazol-3-yl)-3-(4-pyridin-4-yloxyphenyl)urea; p38-MAPK inhibitor

CAS Number: 229002-10-2
Compound CID: 17941505

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

MAPK13-IN-1 targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates.

Molecular Weight

365.43

Molecular Formula

C₂₀H₂₃N₅O₂

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

MAPK13-IN-1 is used in research aimed at understanding the inhibitory effects on MAPK13, a p38 delta kinase, and its potential therapeutic applications.

Storage

Store at -20ºC.